Skip to main content
Medpace Holdings, Inc. logo

Medpace Holdings, Inc. — Investor Relations & Filings

Ticker · MEDP ISIN · US58506Q1094 LEI · 549300H8TYEUVTW14A54 US Professional, scientific and technical activities
Open in API
Filings indexed 859 across all filing types
Latest filing 2016-08-08 Regulatory Filings
Country US United States of America
Listing US MEDP

About Medpace Holdings, Inc.

https://investor.medpace.com/

Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization (CRO) that provides Phase I-IV clinical development services. The company serves the biotechnology, pharmaceutical, and medical device industries, with a mission to accelerate the development of safe and effective medical therapeutics. Medpace employs a disciplined operating approach that leverages regulatory and therapeutic expertise. Its services include clinical pharmacology, central laboratory, bioanalytical, ECG core lab, and imaging core labs. The company has expertise across major therapeutic areas, including oncology, cardiology, metabolic disease, endocrinology, central nervous system, and anti-viral and anti-infective diseases.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2016
Regulatory Filings Classification · 95% confidence The document is a letter from Medpace Holdings, Inc. to the SEC requesting acceleration of the effective date of a Registration Statement on Form S-1. It references the Securities Act of 1933 and the Securities Exchange Act of 1934, and discusses procedural matters related to the registration statement becoming effective. The document is short (2519 characters) and does not contain any financial data or report content itself. It is an official communication related to a regulatory filing but not the filing itself. Therefore, it fits best under Regulatory Filings (RNS) as a procedural correspondence regarding a registration statement.
2016-08-08 English
S-1/A
Regulatory Filings Classification · 100% confidence The document is an S-1/A Registration Statement Amendment No. 2 filed with the SEC by Medpace Holdings, Inc. It is a regulatory filing related to the registration of securities for an initial public offering (IPO). The document includes detailed information typical of a prospectus, such as risk factors, use of proceeds, capitalization, dilution, management discussion and analysis, business description, executive compensation, principal shareholders, and legal matters. It is not a financial report like an annual or quarterly report, nor is it an earnings release or a proxy statement. The S-1 form is a registration statement used for securities offerings under the Securities Act of 1933. Therefore, this document is best classified as a Regulatory Filing (RNS) because it is a regulatory submission to the SEC for securities registration and does not fit into other specific categories like Annual Report or Earnings Release.
2016-08-01 English
Regulatory Filings 2016
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the SEC Division of Corporation Finance regarding a Form S-1 Registration Statement for Medpace Holdings, Inc. It discusses preliminary proposed price range and share number information related to the company's initial public offering (IPO). The letter is dated July 28, 2016, and includes details about the offering price, share numbers, and a reverse stock split. The document is a correspondence supplementing the S-1 filing and does not contain the actual registration statement or prospectus itself. It is a regulatory communication related to the IPO process, not a financial report or announcement of results. Given the nature of the document as a regulatory correspondence related to a registration statement, it fits best under Regulatory Filings (RNS). The document length is under 5,000 characters and it is a letter rather than a full report or prospectus, so it is not a report publication announcement or the registration statement itself.
2016-07-28 English
S-1/A
Capital/Financing Update Classification · 95% confidence The document is an Amendment No. 1 to a Form S-1 Registration Statement filed with the SEC, dated July 26, 2016, for Medpace Holdings, Inc. It is a preliminary prospectus related to an initial public offering (IPO) of common stock. The Form S-1 is a registration statement used by companies planning to go public to register their securities with the SEC. This document includes detailed information about the offering, company background, risk factors, use of proceeds, management, financial data, and other disclosures required for an IPO. It is not an annual report, earnings release, or any other type of financial or governance report. Instead, it is a capital markets filing related to the company's equity offering. According to the filing definitions, updates on company fundraising or financing activities fall under Capital/Financing Update (CAP). Since this is a registration statement for an IPO, it is best classified as a Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it contains the full registration statement text, not just an announcement or notice, so it is not RPA or RNS. Therefore, the appropriate classification is CAP with high confidence.
2016-07-26 English
Regulatory Filings 2016
Regulatory Filings Classification · 100% confidence The document is a letter addressed to the SEC Division of Corporation Finance regarding a confidential treatment request under 17 C.F.R §200.83 related to a Form S-1 registration statement. It discusses details about disclosure in the registration statement and requests confidential treatment of certain information. The document is short (3101 characters) and is a correspondence letter, not a financial report or earnings release. It does not contain financial statements or substantive financial data. It is not an announcement of a report but a regulatory filing related to SEC procedures and confidential treatment requests. Therefore, it fits best under Regulatory Filings (RNS).
2016-07-15 English
Regulatory Filings 2016
Regulatory Filings
2016-07-11 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.